STOCKHOLM, Sweden--(BUSINESS WIRE)--In accordance with Biovitrum’s 2001/2006 warrant programme, 115,000 shares have been issued at SEK 59 per share, with net proceeds of SEK 6,785,000. The remaining 58,500 warrants under the 2001/2006 programme, each entitle to subscribe for two shares, expires on November 30, 2006.
